Clinical characteristics of familial hypocalciuric hypercalcaemia type 1: A multicentre study of 77 adult patients
Autor: | Jean-Philippe Haymann, Anne Lienhardt, Antoine Tabarin, Agnès Linglart, Philippe Caron, Yves Reznik, Thierry Brue, Dominique Martin-Coignard, Ivan Tack, Alexandre Buffet, Rosa Vargas-Poussou, Delphine Vezzosi, Marguerite Hureaux, Caroline Silve, Corinne Magdelaine, Jean-Marc Kuhn, C. Mouly, Solange Grunenwald, Antoine Bennet |
---|---|
Přispěvatelé: | CHU Toulouse [Toulouse], Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), CHU Limoges, Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Rouen, Normandie Université (NU), Marseille medical genetics - Centre de génétique médicale de Marseille (MMG), Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), Service d'endocrinologie, diabète, maladies métaboliques [Hôpital de la Conception - APHM], Aix Marseille Université (AMU), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), CHU Bordeaux [Bordeaux], Centre Hospitalier Le Mans (CH Le Mans), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Gall, Valérie |
Rok vydání: | 2020 |
Předmět: |
Adult
medicine.medical_specialty Hypercalcaemia Endocrinology Diabetes and Metabolism Osteoporosis familial hypocalciuric hypercalcaemia 030209 endocrinology & metabolism Gastroenterology Cohort Studies 03 medical and health sciences 0302 clinical medicine Endocrinology parathyroid adenoma Internal medicine medicine Humans Renal colic primary hyperparathyroidism calcium‐sensing receptor Retrospective Studies Parathyroid adenoma [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology business.industry Middle Aged Hyperparathyroidism Primary medicine.disease Urinary calcium 3. Good health 030220 oncology & carcinogenesis Hypercalcemia Calcium Kidney stones medicine.symptom Differential diagnosis business Receptors Calcium-Sensing [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology Primary hyperparathyroidism |
Zdroj: | Clinical Endocrinology Clinical Endocrinology, Wiley, 2020, 93 (3), pp.248-260. ⟨10.1111/cen.14211⟩ Clinical Endocrinology, 2020, 93 (3), pp.248-260. ⟨10.1111/cen.14211⟩ |
ISSN: | 1365-2265 0300-0664 |
DOI: | 10.1111/cen.14211 |
Popis: | International audience; ObjectiveFamilial hypocalciuric hypercalcaemia type 1 (FHH1), related to heterozygous loss‐of‐function mutations of the calcium‐sensing receptor gene, is the main differential diagnosis for primary hyperparathyroidism. The aim of our study was to describe clinical characteristics of adult patients living in France with a genetically confirmed FHH1.Design and patientsThis observational, retrospective, multicentre study included 77 adults, followed up in 32 clinical departments in France, with a genetic FHH1 diagnosis between 2001 and 2012.ResultsHypercalcaemia was diagnosed at a median age of 53 years [IQR: 38‐61]. The diagnosis was made after clinical manifestations, routine analysis or familial screening in 56, 34 and 10% of cases, respectively, (n = 58; data not available for 19 patients). Chondrocalcinosis was present in 11/51 patients (22%), bone fractures in 8/56 (14%) and renal colic in 6/55 (11%). The median serum calcium was 2.74 mmol/L [IQR: 2.63‐2.86 mmol/L], the median plasma parathyroid hormone level was 4.9 pmol/L [3.1‐7.1], and the median 24‐hour urinary calcium excretion was 2.8 mmol/24 hours [IQR: 1.9‐4.0]. Osteoporosis (dual X‐ray absorptiometry) or kidney stones (renal ultrasonography) were found in 6/38 patients (16%) and 9/32 patients (28%), respectively. Fourteen patients (18%) underwent parathyroid surgery; parathyroid adenoma was found in three patients (21%) and parathyroid hyperplasia in nine patients (64%). No correlation between genotype and phenotype was established.ConclusionThis large cohort study demonstrates that FHH1 clinical characteristics can be atypical in 33 patients (43%). Clinicians should be aware of this rare differential diagnosis in order to adopt an appropriate treatment strategy. |
Databáze: | OpenAIRE |
Externí odkaz: |